Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « ISSN » - entrée « 1756-185X »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1756-1833 < 1756-185X < 1756-8722  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000078 (2020) Joanna Wai Yee Leong [Singapour] ; Peter P. Cheung [Singapour] ; Sajeewani Dissanayake [Singapour] ; Warren Weng Seng Fong [Singapour] ; Keng Hong Leong [Singapour] ; Ying Ying Leung [Singapour] ; Anita Yee Nah Lim [Singapour] ; Nai Lee Lui [Singapour] ; Mona Manghani [Singapour] ; Amelia Santosa [Singapour] ; Melonie Kannamma Sriranganathan [Singapour] ; Ernest Suresh [Singapour] ; Teck Choon Tan [Singapour] ; Gim Gee Teng [Singapour] ; Manjari Lahiri [Singapour]Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis.
000250 (2019) Durga P. Misra [Inde] ; Godasi S R S N K. Naidu [Inde] ; Vikas Agarwal [Inde] ; Aman Sharma [Inde]Vasculitis research: Current trends and future perspectives.
000275 (2019) Kentaro Chino [Japon] ; Tsuneo Kondo [Japon] ; Ryota Sakai [Japon] ; Shuntaro Saito [Japon] ; Yusuke Okada [Japon] ; Akiko Shibata [Japon] ; Takahiko Kurasawa [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon]Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.
000375 (2019) Durga Prasanna Misra [Inde] ; Anupam Wakhlu [Inde] ; Vikas Agarwal [Inde] ; Debashish Danda [Inde]Recent advances in the management of Takayasu arteritis.
000381 (2019) Kenan Barut [Turquie] ; Amra Adrovic [Turquie] ; Sezgin Sahin [Turquie] ; Gurkan Tarcin [Turquie] ; Gulberk Tahaoglu [Turquie] ; Oya Koker [Turquie] ; Mehmet Yildiz [Turquie] ; Ozgur Kasapcopur [Turquie]Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
000446 (2019) Toshiyuki Watanabe [Japon] ; Jun Fukae [Japon] ; Shinji Fukaya [Japon] ; Norifumi Sawamukai [Japon] ; Masato Isobe [Japon] ; Megumi Matsuhashi [Japon] ; Masato Shimizu [Japon] ; Kazumasa Akikawa [Japon] ; Kazuhide Tanimura [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon]Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
000545 (2019) Jumpei Saito [Japon] ; Naho Yakuwa [Japon] ; Kayoko Kaneko [Japon] ; Ken Nakajima [Japon] ; Chinatsu Takai [Japon] ; Mikako Goto [Japon] ; Akimasa Yamatani [Japon] ; Atsuko Murashima [Japon]Clinical application of the dried milk spot method for measuring tocilizumab concentrations in the breast milk of patients with rheumatoid arthritis.
000551 (2019) Sezgin Sahin [Turquie] ; Duhan Hopurcuoglu [Turquie] ; Sule Bektas [Turquie] ; Ezgi Belhan [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Nur Canpolat [Turquie] ; Salim Caliskan [Turquie] ; Lale Sever [Turquie] ; Ozgur Kasapcopur [Turquie]Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center.
000583 (2019) Ediz Dalkilic [Turquie] ; Belk S Nihan Coskun [Turquie] ; Burcu Ya Z [Turquie] ; Yavuz Pehlivan [Turquie]A successful pregnancy in a patient with Takayasu's arteritis under tocilizumab treatment: A longitudinal case study.
000706 (2018) Catherine Chapelon-Abric [France] ; David Saadoun [France] ; Isabelle Marie [France] ; Cloé Comarmond [France] ; Anne Claire Desbois [France] ; Fanny Domont [France] ; Léa Savey [France] ; Patrice Cacoub [France]Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review.
000797 (2018) Kazuha Kizaki [Japon] ; Fumiharu Yamashita [Japon] ; Tomoya Hayashi [Japon] ; Noboru Funakoshi [Japon]Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
000824 (2018) Ying-Chou Chen [Taïwan] ; Wen-Chan Chiu [Taïwan] ; Fu-Mei Su [Taïwan] ; Jia-Feng Chen [Taïwan]Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
000862 (2018) Der-Yuan Chen [Taïwan] ; Chak Sing Lau [Hong Kong] ; Bassel Elzorkany [Égypte] ; Ping-Ning Hsu [Taïwan] ; Sonja Praprotnik [Slovénie] ; Radu Vasilescu [Belgique] ; Lisa Marshall [États-Unis] ; Lyndon Llamado [Philippines]Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature.
000929 (2018) Graeme Jones [Australie] ; Stephen Hall [Australie] ; Paul Bird [Australie] ; Geoff Littlejohn [Australie] ; Kathleen Tymms [Australie] ; Peter Youssef [Australie] ; Eric Chung [Australie] ; Rina Barrett [Australie] ; Peter Button [Australie]A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.
000991 (2017) Tatsuhiko Mori [Japon] ; Toshiyuki Yamamoto [Japon]Tocilizumab-induced pustular drug eruption.
000A01 (2017) Masataka Umeda [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Kaoru Terada [Japon] ; Gou Takeo [Japon] ; Nobuhisa Yonemitsu [Japon] ; Yukitaka Ueki [Japon] ; Kiyoshi Migita [Japon] ; Atsushi Kawakami [Japon]Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis.
000A62 (2017) Le-Feng Chen [République populaire de Chine] ; Ying-Qian Mo [République populaire de Chine] ; Jun Jing [République populaire de Chine] ; Jian-Da Ma [République populaire de Chine] ; Dong-Hui Zheng [République populaire de Chine] ; Lie Dai [République populaire de Chine]Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation.
000B57 (2017) Arman Ahmadzadeh [Iran] ; Alireza N. Farahmand [Iran] ; Latif Gachkar [Iran]Evaluation of safety, efficacy and post-cessation efficacy durability of tocilizumab in patients with active rheumatoid arthritis.
000C51 (2017) Worawit Louthrenoo [Thaïlande] ; Nuntana Kasitanon [Thaïlande] ; Wanruchada Katchamart [Thaïlande] ; Duangkamol Aiewruengsurat [Thaïlande] ; Parawee Chevaisrakul [Thaïlande] ; Praveena Chiowchanwisawakit [Thaïlande] ; Pornchai Dechanuwong [Thaïlande] ; Punchong Hanvivadhanakul [Thaïlande] ; Ajanee Mahakkanukrauh [Thaïlande] ; Siriporn Manavathongchai [Thaïlande] ; Chayawee Muangchan [Thaïlande] ; Pongthorn Narongroeknawin [Thaïlande] ; Veerapong Phumethum [Thaïlande] ; Boonjing Siripaitoon [Thaïlande] ; Anawat Suesuwan [Thaïlande] ; Siraphop Suwannaroj [Thaïlande] ; Parichat Uea-Areewongsa [Thaïlande] ; Sittichai Ukritchon [Thaïlande] ; Paijit Asavatanabodee [Thaïlande] ; Ajchara Koolvisoot [Thaïlande] ; Ratanavadee Nanagara [Thaïlande] ; Kitti Totemchokchyakarn [Thaïlande] ; Kanokrut Nuntirooj [Thaïlande] ; Tasanee Kitumnuaypong [Thaïlande]2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
000D69 (2016) Jun Nakamura [Japon] ; Takao Nagashima [Japon] ; Katsuya Nagatani [Japon] ; Taku Yoshio [Japon] ; Masahiro Iwamoto [Japon] ; Seiji Minota [Japon]Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.
000E98 (2016) Tristan Pascart [France] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/ISSN.i -k "1756-185X" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/ISSN.i  \
                -Sk "1756-185X" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1756-185X
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021